These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6187504)

  • 61. Anticardiolipin antibodies in rheumatoid arthritis.
    Keane A; Woods R; Dowding V; Roden D; Barry C
    Br J Rheumatol; 1987 Oct; 26(5):346-50. PubMed ID: 3664159
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antibody to stratum corneum (antikeratin antibody) and antiperinuclear factor: markers for progressive rheumatoid arthritis.
    Kurki P; von Essen R; Kaarela K; Isomäki H; Palosuo T; Aho K
    Scand J Rheumatol; 1997; 26(5):346-9. PubMed ID: 9385344
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnostic accuracy of anti-keratin antibody for rheumatoid arthritis: a meta-analysis.
    Wang XP; Cheng QY; Gu MM; Leng RX; Fan YG; Li BZ; Ye DQ
    Clin Rheumatol; 2019 Jul; 38(7):1841-1849. PubMed ID: 30810911
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Inflammatory markers in rheumatoid arthritis].
    Ishizuka S; Yasuda M; Kobayashi S; Tsuda H
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():306-9. PubMed ID: 15799367
    [No Abstract]   [Full Text] [Related]  

  • 65. [Quantitation and clinical significance of human serum amyloid A protein].
    Yamada T; Uchiyama K; Yakata M; Nakano M; Gejyo F; Arakawa M
    Rinsho Byori; 1988 Apr; 36(4):459-63. PubMed ID: 3136263
    [No Abstract]   [Full Text] [Related]  

  • 66. Quantitative solid phase fluorescence immunoassay of rheumatoid factor and C-reactive protein in active rheumatoid arthritis.
    Cannon GW; Egger MJ; Ward JR; Blonquist LJ; Collette LB
    Am J Clin Pathol; 1987 Feb; 87(2):223-9. PubMed ID: 3812354
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Colloidal gold sulfate in the therapy of chronic evolutive polyarthritis].
    Colamussi V; Longhini C; Vallini A; Antonioli G; Bazzanini G
    Minerva Med; 1967 Sep; 58(74):3137-58. PubMed ID: 6051031
    [No Abstract]   [Full Text] [Related]  

  • 68. [Serological findings in progressive chronic polyarthritis].
    Römer R
    Beitr Rheumatol; 1973; 20():56-66. PubMed ID: 4775428
    [No Abstract]   [Full Text] [Related]  

  • 69. Serum alpha 1 antichymotrypsin concentration as a marker of disease activity in rheumatoid arthritis.
    Chard MD; Calvin J; Price CP; Cawston TE; Hazleman BL
    Ann Rheum Dis; 1988 Aug; 47(8):665-71. PubMed ID: 3261967
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Early appearance of antikeratin antibodies].
    Le Goff P; Youinou P; Jouquan J
    Rev Rhum Mal Osteoartic; 1986 Dec; 53(12):699-700. PubMed ID: 2434983
    [No Abstract]   [Full Text] [Related]  

  • 71. Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature.
    van der Heijde DM; van Riel PL; van Rijswijk MH; van de Putte LB
    Semin Arthritis Rheum; 1988 May; 17(4):284-92. PubMed ID: 3068804
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Lack of antikeratin antibodies in patients with palmoplantar pustular eruptions and arthropathy.
    Jurik AG; Graudal H; Kirstein H
    Arch Dermatol Res; 1989; 281(3):185-7. PubMed ID: 2476081
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Immunosuppressive therapy of rheumatoid arthritis (progressive chronic polyarthritis) with azathioprine].
    Klein G; Kalb R
    Z Rheumaforsch; 1969; 28(1):1-5. PubMed ID: 5258201
    [No Abstract]   [Full Text] [Related]  

  • 74. Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease.
    Kurki P; Aho K; Palosuo T; Heliövaara M
    Arthritis Rheum; 1992 Aug; 35(8):914-7. PubMed ID: 1379430
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Significance of laminar antikeratin antibodies to rat oesophagus in rheumatoid arthritis.
    Scott DL; Delamere JP; Jones LJ; Walton KW
    Ann Rheum Dis; 1981 Jun; 40(3):267-71. PubMed ID: 6166256
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Symposium: Etiology of rheumatic diseases. 4. (B) A tissue destructing factor in the serum of patients with chronic rheumatoid arthritis].
    Kasukawa R
    Ryumachi; 1973 Oct; 13(4):350-4. PubMed ID: 4802983
    [No Abstract]   [Full Text] [Related]  

  • 77. The many myths of erythrocyte sedimentation rate and C-reactive protein.
    Wolfe F
    J Rheumatol; 2009 Aug; 36(8):1568-9. PubMed ID: 19671807
    [No Abstract]   [Full Text] [Related]  

  • 78. [Clinical observation on rheumatoid arthritis--on the relationship between general and local symptoms].
    Mori Y; Taki M; Sakamoto K; Monma M; Hirai K
    Ryumachi; 1972 Nov; 12(3):208-13. PubMed ID: 4663173
    [No Abstract]   [Full Text] [Related]  

  • 79. A longitudinal study of anticollagen antibodies in patients with rheumatoid arthritis.
    Morgan K; Clague RB; Collins I; Ayad S; Phinn SD; Holt PJ
    Arthritis Rheum; 1989 Feb; 32(2):139-45. PubMed ID: 2465767
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Studies on the anti-Gm antibodies in patients with rheumatoid arthritis].
    Woźniczko-Orlowska G; Weryńska-Przybylska J
    Reumatologia; 1969; 7(2):127-31. PubMed ID: 5307312
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.